Health industry practices that create conflicts of interest - A policy proposal for academic medical centers

被引:490
作者
Brennan, TA
Rothman, DJ
Blank, L
Blumenthal, D
Chimonas, SC
Cohen, JJ
Goldman, J
Kassirer, JP
Kimball, H
Naughton, J
Smelser, N
机构
[1] Harvard Univ, Sch Med, Boston, MA USA
[2] Columbia Univ, Coll Phys & Surg, Inst Med Profess, New York, NY USA
[3] Assoc Amer Med Coll, Washington, DC USA
[4] Tufts Univ, Sch Med, Boston, MA 02111 USA
[5] Univ Washington, Sch Med, Seattle, WA USA
[6] Alliance Med Grp, San Francisco, CA USA
[7] Univ Calif San Francisco, Sch Med, San Francisco, CA USA
[8] Univ Calif Berkeley, Berkeley, CA 94720 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2006年 / 295卷 / 04期
关键词
D O I
10.1001/jama.295.4.429
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Conflicts of interest between physicians' commitment to patient care and the desire of pharmaceutical companies and their representatives to sell their products pose challenges to the principles of medical professionalism. These conflicts occur when physicians have motives or are in situations for which reasonable observers could conclude that the moral requirements of the physician's roles are or will be compromised. Although physician groups, the manufacturers, and the federal government have instituted self-regulation of marketing, research in the psychology and social science of gift receipt and giving indicates that current controls will not satisfactorily protect the interests of patients. More stringent regulation is necessary, including the elimination or modification of common practices related to small gifts, pharmaceutical samples, continuing medical education, funds for physician travel, speakers bureaus, ghostwriting, and consulting and research contracts. We propose a policy under which academic medical centers would take the lead in eliminating the conflicts of interest that still characterize the relationship between physicians and the health care industry.
引用
收藏
页码:429 / 433
页数:5
相关论文
共 32 条
[1]  
Angell M., 2004, TRUTH DRUG CO
[2]  
[Anonymous], 1996, CONFLICTS INTEREST C
[3]  
Avorn J., 2004, Powerful Medicines. The Benefits, Risks
[4]   Scope and impact of financial conflicts of interest in biomedical research - A systematic review [J].
Bekelman, JE ;
Li, Y ;
Gross, CP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (04) :454-465
[5]   Medical professionalism in the new millennium: A physician charter 15 months later [J].
Blank, L ;
Kimball, H ;
McDonald, W ;
Merino, J .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (10) :839-841
[6]   Doctors and drug companies [J].
Blumenthal, D .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (18) :1885-1890
[7]  
Bowman M A, 1988, J Contin Educ Health Prof, V8, P13, DOI 10.1002/chp.4750080104
[8]  
BROTZMAN GL, 1992, J FAM PRACTICE, V34, P54
[9]   The dirt on coming clean: Perverse effects of disclosing conflicts of interest [J].
Cain, DM ;
Loewenstein, G ;
Moore, DA .
JOURNAL OF LEGAL STUDIES, 2005, 34 (01) :1-25
[10]   New federal guidelines for physician-pharmaceutical industry relations: The politics of policy formation [J].
Chimonas, S ;
Rothman, DJ .
HEALTH AFFAIRS, 2005, 24 (04) :949-960